Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Dormant pathogenic CD4+ T cells are prevalent in the peripheral repertoire of healthy mice.

Cebula A, Kuczma M, Szurek E, Pietrzak M, Savage N, Elhefnawy WR, Rempala G, Kraj P, Ignatowicz L.

Nat Commun. 2019 Oct 25;10(1):4882. doi: 10.1038/s41467-019-12820-3.

2.

Cell-based high throughput screening identified a novel compound that promotes regulatory T cells and prevents autoimmune colitis.

Mao R, Liu H, Yi B, Purohit S, Kuczma M, Kraj P, She JX.

Biochem Pharmacol. 2019 Nov;169:113618. doi: 10.1016/j.bcp.2019.08.020. Epub 2019 Aug 23.

PMID:
31449782
3.

TGF-β-mediated enhancement of TH17 cell generation is inhibited by bone morphogenetic protein receptor 1α signaling.

Browning LM, Pietrzak M, Kuczma M, Simms CP, Kurczewska A, Refugia JM, Lowery DJ, Rempala G, Gutkin D, Ignatowicz L, Muranski P, Kraj P.

Sci Signal. 2018 Aug 28;11(545). pii: eaar2125. doi: 10.1126/scisignal.aar2125.

PMID:
30154100
4.

Non-canonicaly recruited TCRαβCD8αα IELs recognize microbial antigens.

Wojciech L, Szurek E, Kuczma M, Cebula A, Elhefnawy WR, Pietrzak M, Rempala G, Ignatowicz L.

Sci Rep. 2018 Jul 18;8(1):10848. doi: 10.1038/s41598-018-29073-7.

5.

The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells.

Kuczma MP, Ding ZC, Li T, Habtetsion T, Chen T, Hao Z, Bryan L, Singh N, Kochenderfer JN, Zhou G.

Oncotarget. 2017 Dec 5;8(67):111931-111942. doi: 10.18632/oncotarget.22953. eCollection 2017 Dec 19.

6.

Adjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cells.

Ding ZC, Habtetsion T, Cao Y, Li T, Liu C, Kuczma M, Chen T, Hao Z, Bryan L, Munn DH, Zhou G.

Sci Rep. 2017 Sep 22;7(1):12168. doi: 10.1038/s41598-017-12488-z.

7.
8.

IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells.

Ding ZC, Liu C, Cao Y, Habtetsion T, Kuczma M, Pi W, Kong H, Cacan E, Greer SF, Cui Y, Blazar BR, Munn DH, Zhou G.

Oncoimmunology. 2016 Apr 25;5(6):e1171445. doi: 10.1080/2162402X.2016.1171445. eCollection 2016 Jun.

9.

Bone Morphogenetic Protein Signaling Regulates Development and Activation of CD4(+) T Cells.

Kuczma M, Kraj P.

Vitam Horm. 2015;99:171-93. doi: 10.1016/bs.vh.2015.05.001. Epub 2015 Jun 27. Review.

PMID:
26279376
10.

Cx3cr1 deficiency in mice attenuates hepatic granuloma formation during acute schistosomiasis by enhancing the M2-type polarization of macrophages.

Ran L, Yu Q, Zhang S, Xiong F, Cheng J, Yang P, Xu JF, Nie H, Zhong Q, Yang X, Yang F, Gong Q, Kuczma M, Kraj P, Gu W, Ren BX, Wang CY.

Dis Model Mech. 2015 Jul 1;8(7):691-700. doi: 10.1242/dmm.018242. Epub 2015 Apr 21.

11.

Altered connexin 43 expression underlies age-dependent decrease of regulatory T cell suppressor function in nonobese diabetic mice.

Kuczma M, Wang CY, Ignatowicz L, Gourdie R, Kraj P.

J Immunol. 2015 Jun 1;194(11):5261-71. doi: 10.4049/jimmunol.1400887. Epub 2015 Apr 24.

12.

MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis.

Zhong J, Yu Q, Yang P, Rao X, He L, Fang J, Tu Y, Zhang Z, Lai Q, Zhang S, Kuczma M, Kraj P, Xu JF, Gong F, Zhou J, Wen L, Eizirik DL, Du J, Wang W, Wang CY.

J Autoimmun. 2014 Sep;53:95-104. doi: 10.1016/j.jaut.2014.05.006. Epub 2014 Jun 14.

PMID:
24934598
13.

Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.

Kuczma M, Kurczewska A, Kraj P.

J Immunotoxicol. 2014 Oct;11(4):319-27. doi: 10.3109/1547691X.2013.864736. Epub 2013 Dec 19.

14.

SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses.

Yang P, Zhang Y, Xu J, Zhang S, Yu Q, Pang J, Rao X, Kuczma M, Marrero MB, Fulton D, Kraj P, Su Y, Wang CY.

Am J Transl Res. 2013 May 24;5(4):427-40. Print 2013.

15.

Connexin 43 signaling enhances the generation of Foxp3+ regulatory T cells.

Kuczma M, Lee JR, Kraj P.

J Immunol. 2011 Jul 1;187(1):248-57. doi: 10.4049/jimmunol.1003785. Epub 2011 Jun 3.

16.

[Patients's with aphasia communication problems].

Matuszak K, Bonikowska A, Kuczma M, Hagner W.

Wiad Lek. 2011;64(4):310-2. Review. Polish.

PMID:
22533158
17.

Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.

Kuczma M, Kopij M, Pawlikowska I, Wang CY, Rempala GA, Kraj P.

PLoS One. 2010 Oct 26;5(10):e13623. doi: 10.1371/journal.pone.0013623.

18.

Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset.

Kuczma M, Podolsky R, Garge N, Daniely D, Pacholczyk R, Ignatowicz L, Kraj P.

J Immunol. 2009 Sep 15;183(6):3731-41. doi: 10.4049/jimmunol.0800601. Epub 2009 Aug 26.

19.

TCR repertoire and Foxp3 expression define functionally distinct subsets of CD4+ regulatory T cells.

Kuczma M, Pawlikowska I, Kopij M, Podolsky R, Rempala GA, Kraj P.

J Immunol. 2009 Sep 1;183(5):3118-29. doi: 10.4049/jimmunol.0900514. Epub 2009 Jul 31.

20.

Instability of hybrid plasmids in Bacillus subtilis.

Wójcik K, Wieckiewicz J, Kuczma M, Porwit-Bóbr Z.

Acta Microbiol Pol. 1993;42(2):127-36.

PMID:
7509557
21.

[Personal experience and the results of surgical treatment of blepharoptosis].

Bartkowski SB, Krzystkowa KM, Kuczma M.

Klin Oczna. 1991 Jun;93(6):164-6. Polish.

PMID:
1942918

Supplemental Content

Loading ...
Support Center